McMillion Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2.11M Sell
18,312
-615
-3% -$69.8K 1.88% 15
2023
Q1
$2.01M Sell
18,927
-1,571
-8% -$170K 1.9% 15
2022
Q4
$2.27M Sell
20,498
-365
-2% -$37.3K 2.06% 13
2022
Q3
$1.8M Sell
20,863
-1,350
-6% -$121K 1.66% 15
2022
Q2
$2.02M Sell
22,213
-4,453
-17% -$395K 1.69% 16
2022
Q1
$2.19M Sell
26,666
-2,027
-7% -$160K 1.35% 28
2021
Q4
$2.2M Sell
28,693
-592
-2% -$47.2K 1.19% 34
2021
Q3
$2.2M Sell
29,285
-84
-0.3% -$6.39K 1.29% 30
2021
Q2
$2.28M Sell
29,369
-3,337
-10% -$248K 1.24% 33
2021
Q1
$2.41M Buy
32,706
+833
+3% +$61.4K 1.41% 27
2020
Q4
$2.49M Sell
31,873
-34
-0.1% -$2.6K 1.51% 25
2020
Q3
$2.52M Sell
31,907
-1,549
-5% -$121K 1.9% 20
2020
Q2
$2.47M Sell
33,456
-7,550
-18% -$568K 1.63% 22
2020
Q1
$3.01M Sell
41,006
-654
-2% -$51.4K 2.05% 17
2019
Q4
$3.62M Sell
41,660
-241
-0.6% -$19.8K 1.74% 21
2019
Q3
$3.37M Sell
41,901
-875
-2% -$70.1K 1.79% 21
2019
Q2
$3.42M Sell
42,776
-393
-0.9% -$30.1K 1.81% 24
2019
Q1
$3.43M Buy
43,169
+1,008
+2% +$75.4K 1.86% 22
2018
Q4
$3.07M Buy
+42,161
New +$2.98M 1.98% 21
2014
Q3
Sell
-68,793
Closed -$3.8M 70
2014
Q2
$3.8M Buy
68,793
+1,386
+2% +$75.6K 2.2% 18
2014
Q1
$3.65M Sell
67,407
-425
-0.6% -$22K 2.22% 17
2013
Q4
$3.24M Sell
67,832
-1,247
-2% -$57K 1.97% 25
2013
Q3
$3.14M Sell
69,079
-1,022
-1% -$46.7K 2.24% 24
2013
Q2
$3.11M Buy
+70,101
New +$3.13M 2.29% 21

Other funds holding MRK

McMillion Capital Management's MRK Position: Q2 2023 in Review

McMillion Capital Management reduced its Merck (MRK) stake by 3.2% in Q2 2023, selling an estimated $69.8K and leaving 18,312 shares worth $2.11M. The position accounts for 1.88% of the portfolio, ranked #15.

McMillion Capital Management first reported a position in MRK in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.8M in Q2 2014. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • McMillion Capital Management held 18,312 shares of Merck worth $2.11M as of Q2 2023.
  • McMillion Capital Management sold 615 Merck shares in Q2 2023, an estimated $69.8K.
  • Merck made up 1.88% of McMillion Capital Management's portfolio in Q2 2023, its #15 holding.
  • McMillion Capital Management first reported a position in Merck in Q2 2013 and has held it in 24 quarters since.
  • McMillion Capital Management's Merck position peaked at $3.8M in Q2 2014.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.